Dry eye remains one of the more dynamic sectors of ophthal-mology with Shire’s recent news about its lead Lifitegrast product moving toward FDA approval. Ora knows Dry Eye better than most, and Vice President George Ousler helps fill in the blanks about Dry Eye’s future. Ora also published a paper in the October issue of Review of Ophthal-mology, Delving into the Dry-Eye Pipeline. To access the paper, go here. http://www.oraclinical.com/articles/delving-dry-eye-pipeline